Trump to Launch Federal Research on Psychedelic Drug Ibogaine for PTSD
Trump plans to boost research on ibogaine for PTSD in veterans, despite safety concerns and its illegal status in the US.
/ 8 items
Trump plans to boost research on ibogaine for PTSD in veterans, despite safety concerns and its illegal status in the US.
Jefferies initiated coverage on Definium Therapeutics with a Buy rating, citing strong Phase IIb results for its anxiety drug DT120 and high confidence ahead of Phase III trials.